Price
Financials
Consolidated, Rs crore| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 333 | 349 | 403 | 417 | 431 | 460 | 487 | 499 | 530 | 564 | 614 |
| Expenses | 244 | 241 | 300 | 310 | 316 | 329 | 360 | 363 | 386 | 403 | 444 |
| Operating Profit | 89 | 108 | 104 | 107 | 115 | 131 | 128 | 136 | 144 | 161 | 170 |
| OPM % | 27% | 31% | 26% | 26% | 27% | 28% | 26% | 27% | 27% | 29% | 28% |
| Other Income | 12 | 20 | 6 | 12 | 13 | 13 | 13 | 8 | 11 | 14 | 6 |
| Interest | 22 | 27 | 27 | 28 | 28 | 25 | 25 | 23 | 21 | 22 | 23 |
| Depreciation | 43 | 47 | 56 | 57 | 58 | 60 | 63 | 68 | 69 | 77 | 78 |
| Profit before tax | 36 | 54 | 27 | 33 | 41 | 59 | 54 | 54 | 65 | 77 | 75 |
| Tax % | 37% | 24% | 33% | 36% | 31% | 27% | 29% | 32% | 33% | 35% | 27% |
| Net Profit | 23 | 41 | 18 | 21 | 28 | 43 | 38 | 36 | 44 | 50 | 55 |
| EPS in Rs | 0.72 | 1.03 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 531 | 471 | 696 | 1,018 | 1,332 | 1,711 | 2,080 | 2,207 |
| Expenses | 407 | 387 | 510 | 743 | 965 | 1,248 | 1,503 | 1,595 |
| Operating Profit | 124 | 85 | 186 | 275 | 367 | 463 | 577 | 612 |
| OPM % | 23% | 18% | 27% | 27% | 28% | 27% | 28% | 28% |
| Other Income | 13 | 6 | 17 | 14 | 44 | 43 | 46 | 39 |
| Interest | 54 | 44 | 49 | 76 | 101 | 115 | 98 | 89 |
| Depreciation | 93 | 95 | 98 | 128 | 170 | 231 | 276 | 292 |
| Profit before tax | -11 | -48 | 57 | 84 | 141 | 160 | 249 | 270 |
| Tax % | 82% | 21% | 24% | -24% | 32% | 31% | 32% | |
| Net Profit | -21 | -59 | 43 | 103 | 95 | 110 | 168 | 185 |
| EPS in Rs | 2.64 | 4.20 | 4.69 | |||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 35% | 27% | 23% | ||
| Compounded Profit Growth | % | 33% | 9% | 43% | ||
| Stock Price CAGR | % | % | % | -2% | ||
| Return on Equity | % | 7% | 6% | 6% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 8 | 9 | 32 | 32 |
| Reserves | 242 | 177 | 206 | 622 | 1,330 | 1,835 | 1,994 |
| Borrowings | 162 | 185 | 633 | 857 | 966 | 961 | 1,066 |
| Other Liabilities | 339 | 417 | 179 | 336 | 445 | 837 | 849 |
| Total Liabilities | 751 | 787 | 1,025 | 1,823 | 2,751 | 3,665 | 3,941 |
| Fixed Assets | 551 | 575 | 701 | 1,293 | 1,746 | 2,523 | 2,870 |
| CWIP | 8 | 11 | 28 | 99 | 118 | 153 | 244 |
| Investments | 1 | 0 | 0 | 34 | 471 | 264 | 152 |
| Other Assets | 192 | 201 | 295 | 397 | 416 | 724 | 675 |
| Total Assets | 751 | 787 | 1,025 | 1,823 | 2,751 | 3,665 | 3,941 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 103 | 99 | 164 | 233 | 346 | 357 | 519 |
| Cash from Investing Activity | -85 | -46 | -155 | -509 | -914 | -750 | -308 |
| Cash from Financing Activity | -73 | -37 | 35 | 303 | 553 | 382 | -220 |
| Net Cash Flow | -56 | 17 | 44 | 27 | -15 | -11 | -10 |
| Free Cash Flow | -98 | 66 | 95 | 76 | 118 | 37 | 59 |
| CFO/OP | 97% | 126% | 97% | 98% | 103% | 85% | 99% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 36 | 36 | 30 | 27 | 27 | 26 | 28 |
| Inventory Days | 178 | 169 | 144 | 116 | 138 | 181 | 178 |
| Days Payable | 340 | 452 | 389 | 326 | 355 | 286 | 283 |
| Cash Conversion Cycle | -126 | -247 | -215 | -183 | -190 | -79 | -76 |
| Working Capital Days | -31 | -47 | -50 | -62 | -65 | -43 | -30 |
| ROCE % | -1% | 17% | 13% | 11% | 10% | 11% |
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Promoters | 32.45% | 32.43% | 32.43% | 32.39% | 32.35% | 32.34% |
| FIIs | 60.62% | 59.26% | 58.13% | 58.06% | 57.94% | 57.97% |
| DIIs | 5.21% | 6.44% | 7.92% | 7.78% | 7.83% | 7.72% |
| Public | 1.74% | 1.87% | 1.52% | 1.78% | 1.87% | 1.97% |
| No. of Shareholders | 68,696 | 63,021 | 48,168 | 46,554 | 43,538 | 42,492 |
Fundamentals
Market Cap₹ 15,701 Cr.
Current Price₹ 495
Stock P/E106
Book Value₹ 63.9
ROCE10.9 %
ROE5.99 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)23%
Compounded Profit Growth (TTM)43%
Consolidated figures.
Valuation
Market capRs 15,422 Cr
Enterprise valueRs 16,131 Cr
P/E (TTM)103.94x
Price to book24.50x
Price to sales6.99x
EV / EBITDA24.78x
EV / EBIT44.89x
EV / sales7.31x
Price to cash flow66.16x
Earnings yield0.96%
Profitability
Operating margin (excl. other income)27.00%
Operating margin (incl. other income)28.33%
EBITDA margin29.50%
Pre-tax margin12.24%
Net profit margin6.72%
Net margin, latest quarter7.37%
ROE22.35%
ROCE13.73%
ROA6.61%
ROE, 3-year average5.25%
ROCE, 3-year average10.01%
ROA, 3-year average1.18%
ROIC (approx.)33.15%
Tax rate-23.50%
Other income / net worth2.15%
Growth
Sales growth (latest year)46.24%
Profit growth (latest year)149.67%
Sales CAGR, 3 years24.24%
Sales growth QoQ8.85%
Profit growth QoQ13.90%
Sales growth YoY (latest quarter)25.97%
Profit growth YoY (latest quarter)50.52%
Per share
EPS (TTM)Rs 4.68
EPS (latest year)Rs 118.72
EPS (latest quarter)Rs 1.43
EPS, 3-year averageRs 30.93
Book value per shareRs 19.86
Sales per shareRs 69.61
Cash flow per shareRs 7.35
Free cash flow per shareRs 1.86
Efficiency
Asset turnover0.56x
Fixed asset turnover0.79x
Inventory turnover7.98x
Inventory days46 days
Debtor days27 days
Debtors turnover13.34x
Creditor days283 days
Cash conversion cycle-76 days
Working capital days-30 days
Leverage
Total debtRs 857 Cr
Cash and bankRs 149 Cr
Net debtRs 709 Cr
Debt to equity1.36x
Net debt / EBITDA1.09x
Interest coverage4.03x
Current ratio (filing 2026-03-31)1.24x
Quick ratio (filing 2026-03-31)1.04x
Trade payables (filing 2026-03-31)Rs 149 Cr
Owners' fund to total sources34.54%
Debt to assets47.04%
Cash flow
Cash from Operating Activity (latest year)Rs 233 Cr
Cash from Investing Activity (latest year)Rs -509 Cr
Cash from Financing Activity (latest year)Rs 303 Cr
Net Cash Flow (latest year)Rs 27 Cr
Free cash flow (latest year)Rs 59 Cr
FCFE (approx.: FCF + change in debt)Rs 283 Cr
Cash from ops / profit, 5 years3.12x
Sales to cash flow4.37x
Statement figures
Net sales (TTM)Rs 2,207 Cr
Net sales (latest year)Rs 1,018 Cr
Sales (latest quarter)Rs 614 Cr
Operating profit excl. other income (latest year)Rs 275 Cr
Operating profit (latest quarter)Rs 170 Cr
Other income (TTM)Rs 39 Cr
EBITDA (TTM)Rs 651 Cr
PBDT (TTM)Rs 562 Cr
Profit before tax (TTM)Rs 270 Cr
Tax (latest year)Rs -20 Cr
Net profit (TTM)Rs 148 Cr
Net profit (latest year)Rs 94 Cr
Net profit (latest quarter)Rs 45 Cr
Depreciation (TTM)Rs 292 Cr
Depreciation (latest quarter)Rs 78 Cr
Interest (TTM)Rs 89 Cr
Cost of goods sold (latest year)Rs 287 Cr
Total expenditure (latest year)Rs 743 Cr
Total income (latest year)Rs 1,031 Cr
Share capitalRs 8 Cr
ReservesRs 622 Cr
Shareholders' fundsRs 630 Cr
Total assetsRs 1,823 Cr
Net blockRs 1,293 Cr
Capital work in progressRs 99 Cr
InvestmentsRs 34 Cr
ReceivablesRs 76 Cr
InventoryRs 36 Cr
Other liabilitiesRs 336 Cr
Shares outstanding (crore)31.70
Ownership
Promoter holding32.34% (-0.09 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | AGARWALEYE | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -3.1% | -2.8% | -0.3 pts |
| 1 month | -4.4% | -6.8% | +2.4 pts |
| 3 months | +1.9% | -7.6% | +9.5 pts |
| 6 months | +19.7% | +0.4% | +19.2 pts |
| 1 year | +0.4% | -9.9% | +10.4 pts |
43 mutual fund schemes hold about ₹2,345 Cr.
Over three months 25 bought more and 4 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Invesco India Smallcap Fund | 2.44% | 385 | +55% |
| ICICI Pru Aggressive Hybrid Fund(A | 0.47% | 249 | +100% |
| Motilal Oswal Small Cap Fund | 3.04% | 248 | +1% |
| ICICI Pru Healthcare Fund- | 2.79% | 195 | +100% |
| Invesco India Large & Mid Cap Fund | 1.29% | 152 | +100% |
| Invesco India Midcap Fund | 0.73% | 115 | -9% |
| Invesco India Multicap Fund | 2.29% | 104 | -0% |
| ICICI Pru ELSS-Tax Saver Fund | 0.72% | 103 | +100% |
| ICICI Pru Flexi Cap Fund | 0.40% | 103 | +100% |
| ICICI Pru Small Cap Fund | 1.04% | 103 | +100% |
| ICICI Pru Small Cap Fund | 1.04% | 100 | +100% |
| Tata Multi Asset Allocation Fund | 1.56% | 82 | +53% |
| ICICI Pru Innovation Fund | 0.77% | 60 | +100% |
| Invesco India Flexi Cap Fund | 0.89% | 51 | -3% |
| Bandhan Innovation Fund | 1.50% | 40 | +10% |
| LIC MF Multi Cap Fund | 1.30% | 29 | +16% |
| Invesco India ELSS Tax Saver Fund | 1.04% | 29 | +100% |
| PGIM India Small Cap Fund | 1.54% | 28 | -3% |
| PGIM India Midcap Fund | 0.20% | 22 | +3% |
| Bandhan Large Cap Fund | 1.00% | 22 | +18% |
| Bandhan Aggressive Hybrid Fund | 0.77% | 20 | +16% |
| ICICI Pru Quality Fund | 0.72% | 15 | +100% |
| LIC MF ELSS Tax Saver Fund | 1.49% | 15 | +19% |
| Invesco India Consumption Fund | 2.53% | 15 | +100% |
| LIC MF Small Cap Fund | 1.54% | 13 | +100% |
Red flags
F-score 6 of 8| look | Share dilution Share count up 16% in a year, 16% in three |
| look | Auditor change Auditor change 2025-11-12: Dr. Agarwal's Health Care Limited has informed the Exchange regarding Change in Auditors of the company. |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹614 Cr +26.1% vs Jun 2025.
Net profit ₹55 Cr +44.7%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
| Artemis Medicare Services Ltd | 5,818 | 50.4 | 14.5 % |
No bulk or block deals on record.
No corporate actions on record.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)
Quick answers
What is the market cap of Dr Agarwals Health Care Ltd?
Dr Agarwals Health Care Ltd (AGARWALEYE) has a market capitalisation of Rs 15,701 Cr. at the 2026-10-01 close.
What is the P/E ratio of Dr Agarwals Health Care Ltd?
Dr Agarwals Health Care Ltd trades at a P/E of 106 on trailing twelve-month profit, at the 2026-10-01 close.
What were Dr Agarwals Health Care Ltd's latest quarterly results?
In the Jun 2026 quarter, Dr Agarwals Health Care Ltd sales was Rs 614 Cr (+26.1% vs Jun 2025) and net profit was Rs 55 Cr.
What is the 52-week high and low of Dr Agarwals Health Care Ltd?
The 52-week high is Rs 568.00 and the 52-week low is Rs 401.00.